ABSTRACT: Background: Recanalization rates and patient outcomes in acute occlusion of the carotid terminus have previously been poor. The use of stent-retrievers has resulted in better recanalization and patient outcomes. We sought to compare outcomes in patients treated with stent-retrievers to outcomes in older techniques. Methods: We retrospectively compared a stent-retriever cohort to a historical cohort. We evaluated recanalization rates and good outcomes (defined as mRS < 2 at 30 days or 10 point drop in NIHSS). Results: There were twenty patients treated with stent-retrievers versus nine without. The recanalization rate in patients treated with stent retrievers was significantly higher than that of other modalities (90% vs 33%, p=0.004). Good outcomes were significantly higher in the stent retriever cohort (70% vs 22%, p=0.041). Conclusion: The use of stent-retrievers in patients with carotid "T" occlusions shows promise in comparison to older techniques. A randomized trial comparing stent-retriever therapy to IV thrombolysis is warranted to determine the efficacy of this new generation of devices.
prognosis in the setting of acute stroke, with a natural history that carries greater than 50% mortality. 1 The poor clinical outcomes are likely related to the occlusion of circle of Willis collaterals and prior limited strategies to remove large clot volumes. 2, 3 Previous endovascular recanalization strategies in carotid T occlusions such as pharmaceutical thrombolysis, angioplasty, earlier generation mechanical retrieval and thromboaspiration had variable results. 1, 2, [4] [5] [6] [7] Stent retrievers have been shown to improve recanalization rates, morbidity and mortality in acute large vessel stroke (internal carotid artery [ICA] , M1 or M2 branches of the middle cerebral artery [MCA] or the vertebrobasilar artery) (Figure 1 ). [8] [9] [10] [11] [12] However, data are lacking regarding outcomes in carotid T occlusions treated with stent retrievers.
Recent interventional trials failed to show improved clinical outcomes when compared with intravenous (IV) thrombolysis alone. 13 However, these trials largely preceded the introduction of stent retrievers. Given the improved recanalization rates with stent retrievers and the large volume of clot often encountered in patients with carotid T occlusion, we sought to evaluate the outcomes of patients with acute anterior circulation T occlusions treated at a single academic stroke referral centre.
METHODS

Study Population
Institutional ethics review board approval was obtained. We retrospectively reviewed consecutive patients that underwent intra-arterial therapy for acute thromboembolic stroke between January 2010 and April 2013 at an academic stroke referral centre. The study interval that was chosen as our prior cohort of acute stroke patients had been previously analyzed. 14 We obtained patient data from electronic health records and clinical chart reviews. The clinical data were reviewed independently by a clinical stroke neurology fellow trained in National Institutes of Health Stroke Scale (NIHSS) assessment with experience in managing acute stroke codes and administration of IV tissue plasminogen activator (tPA).
All patients presenting with acute stroke in our institution have an unenhanced head CT. Patients with a clinical suspicion of proximal vessel occlusion have a CT angiography (CTA) of the neck and brain performed. Depending on scanner availability, CT perfusion is also performed simultaneously with CTA of the brain.
At our institution, the following criteria are applied to determine patient suitability for endovascular stroke therapy in the anterior circulation:
1. Patients with acute strokes presenting <6 hours from onset or wake-up strokes with salvageable brain suspected on imaging defined as <one-third CA territory hypodensity on unenhanced CT or a time-to-peak to cerebral blood volume mismatch of >25% on CT perfusion. 2. NIHSS > 7.
CT showing no intracerebral hemorrhage and Alberta Stroke
Program Early CT score ≥7. 4. Endovascular therapy can be initiated within 6 hours of symptom onset for an anterior circulation thrombus. In the case of wake-up strokes, patients with CT Alberta Stroke Program Early CT ≥7 can also receive this therapy.
Our inclusion criteria for this study were the following:
1. CTA demonstrating carotid T occlusion. 2. Patient fulfilling criteria for endovascular therapy for acute anterior circulation stroke.
Endovascular Treatments
Endovascular treatment of acute stroke has been performed at our institution since 2000. A variety of intra-arterial techniques have been used, including: intra-arterial tPA, balloon angioplasty, microcatheter clot maceration, mechanical retrievers (MERCI, Concentric Medical, Mountain View, CA), thromboaspiration (Penumbra System, Penumbra, Inc., Alameda, CA) and stent retrievers (Solitaire AB, Covidien/ev3, Dublin, Ireland; Trevo, Concentric Medical, Mountain View, CA).
Informed consent was obtained from the patient or next of kin. We performed all cases under conscious sedation unless there were respiratory or cardiovascular concerns necessitating general anaesthesia. After femoral arterial access was obtained, a 2000 U heparin bolus is usually given unless IV tPA had already been administered. Cerebral angiography was performed and a decision was made on what treatment approach to employ at the discretion of the neurointerventionalist.
Stent retrievers, such as the Solitaire and Trevo devices used in this study, combine clot retrieval and proximal flow arrest with aspiration performed during clot retrieval. An 8 Fr balloon aspiration catheter (MERCI) was placed into the ICA above the carotid bulb. Under roadmap guidance, a microcatheter (Prowler Select Plus, Codman Neurovascular, Codman & Shurtleff, Inc., Raynham, MA; or Trevo microcatheter, Concentric Medical) over a 0.010-or 0.014-inch wire was advanced into the MCA distal to the T occlusion. A small test injection of contrast was performed to confirm adequate placement for stent deployment. Either a Solitaire AB (off-label use, before availability of flow-restoration [FR]) or a Trevo stent retriever was advanced into the M1 segment and deployed. A guide catheter angiogram was performed to determine if temporary clot bypass had been achieved. Five minutes later, after proximal balloon inflation for flow arrest, we retrieved the stent retriever under aspiration with a 60-mL syringe attached to the side port of the balloon guide. We visually inspected the stent to determine if the clot had been extracted. If there was no back-bleeding in the balloon guide after stent retrieval, we removed the guide catheter to evaluate if the clot was lodged in the guide.
Variables of Interest
We obtained patient baseline characteristics including demographic information (age, gender), stroke risk factors (hypertension, diabetes, dyslipidemia, coronary arterial disease, peripheral vascular disease, internal carotid stenosis, prior stroke, atrial fibrillation), baseline NIHSS scores and intravenous tPA use.
Baseline non-contrast CT (NCCT), CTA and angiographic images and reports were reviewed retrospectively and thrombus location was confirmed by a single interventional neuroradiologist (12 years' experience) blinded to the clinical outcome.
Outcome variables obtained included percentages of both groups for recanalization rate, mortality, symptomatic intracranial hemorrhage (Eastern Cooperative Acute Stroke Study III definition 15 ), good outcomes, time to recanalization (puncture to stent deployment) and length of hospital stay in each group.
We defined two groups of good clinical outcomes:
1. modified Rankin Score (mRS) at 30 days less than or equal to 2. 2. Either an mRS ≤ 2 at 30 days or a 10-point reduction in the NIHSS at 30 days after treatment.
We used a similar outcome metric compared with other studies; however, we chose a more stringent criteria for improved NIHSS. 10 Recanalization was graded using Thrombolysis in Cerebral Infarction criteria. 16 Successful recanalization was defined as achieving Thrombolysis in Cerebral Infarction grade 2 (a or b) or higher. 9 
Statistical Analysis
Baseline characteristics of both groups were compared with a Fisher's exact test for the categorical variables (gender, use of IV tPA, hypertension, dyslipidemia, smoking, atrial fibrillation, ICA stenosis, diabetes, prior stroke/transient ischemic accident, peripheral vascular disease, coronary arterial disease) and a Mann-Whitney test for continuous, nonparametric variables (age, baseline NIHSS score).
Categorical outcome variables in both groups were also compared with Fisher's exact tests (recanalization rates, good clinical outcome rates, mortality, symptomatic intracranial hemorrhage). Continuous outcome variables (length of stay, time to recanalization) in both groups were compared with a Mann-Whitney test. A p value < 0.05 was considered statistically significant. All statistical analysis was performed with SPSS 20 software (IBM, Armonk, NY).
RESULTS
There were 70 patients, of which 57 had anterior circulation strokes. There were 44 patients treated with stent retrievers, of which 42 had anterior circulation strokes. Our study population consisted of 29 patients with carotid T occlusions: 20 carotid T patients (48% of anterior circulation strokes) identified between August 2011 to April 2013 (group 1) compared with 9 (36%) between July 2010 and November 2011. In group 2, two patients had only intra-arterial tPA, three were treated with thromboaspiration with Penumbra only, two were primarily treated with angioplasty and intra-arterial tPA, one was treated with Penumbra and intra-arterial tPA and one was treated with Penumbra followed first by a rescue attempt with the Solitaire stent retriever. There was an equal proportion of stentretriever cases treated with Solitaire and Trevo. Six of 10 (60%) Solitaire cases were treated with a 6-mm diameter stent and four (40%) were treated with a 4-mm diameter stent.
There were no significant differences in the baseline characteristics ( Table 1 ). The median age in group 1 was 74 and 65 in group 2. IV tPA was used in 60% of patients in group 1 and 88% of patients in group 2. The baseline NIHSS scores were 18 and 19 in groups 1 and 2, respectively. Table 2 summarizes the difference in outcomes between the two groups. The recanalization rates in patients treated with stent retrievers was significantly higher than other modalities (90% vs 33%, p = 0.004). There was a trend towards good outcomes in patients treated with stent retrievers (44% vs 11%, p = 0.19). When a drop in NIHSS >10 was also considered, good outcomes were significantly higher in the stent retriever cohort (70% vs 22%, p = 0.041). The time to recanalization was shorter in the stent retriever group (66 vs 98 minutes, p = 0.06). There was a tendency toward lower mortality rates (15% vs 33%, p = 0.338) and lower rates of symptomatic intracerebral hemorrhage (0 vs 11%, p = 0.310) in the stent-retriever group.
DISCUSSION
Recanalization rates in acute stroke are strongly associated with improved functional outcomes and reduced mortality. 17 The immediate aim of acute stroke treatment is recanalization of the occluded vessel and reperfusion of the ischemic brain. Currently the only proven therapy in acute stroke is intravenous thrombolysis performed within 4.5 hours from stroke onset. 15, 18 Large vessel occlusions are difficult to recanalize, likely because of large volumes of clot. When the occlusion involves an internal carotid terminus, the recanalization rates with IV tPA are low at 4.4%. 17 This has prompted the use of endovascular therapies that have improved recanalization rates up to 60-77%, depending on the clot location. 13, 17 However, previous randomized controlled trials failed to show benefit in functional outcome with the use of additional endovascular therapy compared with standard IV therapy. 13, 19 Stent retrievers in acute large-vessel stroke have shorter recanalization times, improved recanalization rates and better clinical outcomes compared with other endovascular devices. 9, 10, [20] [21] [22] [23] [24] The 48% of patients in our study with carotid T occlusions was higher than other reported series (16-32%). 5, 7 Our stent-retriever recanalization rate was significantly higher than our prior cohort of carotid T occlusions treated with multimodality therapy. This higher rate of recanalization appears to be consistent regardless of the type or diameter of stent retriever used. Our results with stent retrievers also have improved recanalization rates compared with other published series of T occlusions.
1,2,4-7 We had 44% good outcomes (70% when ten-point drop in NIHSS was included) as evaluated by mRS ≤ 2. This compares favorably with prior studies of terminus occlusions, with good outcomes (mRS ≤ 2) seen in a proportion of patients ranging from 16 to 33%. 1, 2, [4] [5] [6] [7] In a large cohort of ICA occlusions, Fischer et al reported good outcomes in only 16% of carotid T occlusions. Recently, Yoon, et al evaluated their experience with stent retrievers in a cohort of 26 patients with intracranial ICA occlusion. 25 They demonstrated 77% recanalization and 39% good outcomes; however, there was no comparison group in this study. Kwak et al reported 79% recanalization and 43% good outcomes in a subset of 14 ICA terminus occlusions. 26 More recently, good outcomes ranging from 20 to 24% have been reported in larger series. 27, 28 Our study and other recent trials provide promising preliminary data 9, 10 ; however, the efficacy of these new devices compared with IV tPA remains to be demonstrated in a randomized trial.
Our study has several limitations: the data were retrospectively collected, historical controls were used and the cohorts were nonrandomized and retrospectively analyzed. Subsequently, the study was subject to potential confounders. In particular, the cohort of non-stent retriever cases had smaller numbers and was performed earlier (from July 2010 to November 2011). The stentretriever cases, on the other hand, were performed from December 2011 to March 2013. Although no changes in management were noted to occur during this period, an unknown confounder in the treatment algorithm is theoretically possible. Our proportion of good outcomes was statistically significant when criteria similar to the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution-2 study 29 were used; however, it was not statistically significant when only mRS was considered. This may be due to our small sample size. Finally, as in other trials, our clinical follow-up was limited to 30 days. 29, 30 
CONCLUSION
In patients presenting with acute stroke secondary to carotid T occlusions, the use of stent retrievers were associated with improved recanalization rates, recanalization times and neurological outcomes compared with a historical cohort treated with other endovascular strategies. These data are encouraging given the large clot volumes and prior poor clinical results previously experienced with endovascular therapy in acute carotid T occlusion. A randomized trial comparing stent-retriever therapy to IV tPA is warranted to determine the efficacy of this new generation of devices.
